Vendor, Roswell, GA, part of DFW Capital Partners
Saol Therapeutics Inc.
UEI RENXP8AP8NW9, CAGE 7P8V3
1 award and $0 obligated between April 25, 2024 and April 25, 2024, 100% under full and open competition, against 999.0 offers on average where reported.
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| V797D70158April 25, 2024, Full and Open Competition, 999 offers | Nac Federal Supply ScheduleDepartment of Veterans Affairs | Product DeletionNAICS 325412, PSC 6505 | $0 |
- Product and service codes
- 6505 Drugs and Biologicals
- Transactions
- 3 across 1 awards